Literature DB >> 454559

Peripheral electrophysiological parameters in mice treated with misonidazole.

R Von Burg, P J Conroy, W Passalacqua.   

Abstract

The clinical use of the radiosensitizer misonidazole may be limited by the incidence of peripheral neuropathy reported following total doses in excess of 18 g. A recent report noted a decrease in nerve conduction velocity following a single i.p. injection of 1 mg/g misonidazole in mice. The present study was unable to confirm such changes when nerve conduction velocity measurements were made in situ or in isolated sural, tibial or median nerves of mice. Other electrophysiological parameters such as threshold, strength-duration curves, refractory time or the ability to carry high-frequency stimulation also showed no change. However, it was noted that a single administration of the radio-sensitizer produced a marked decrease in body temperature which persisted for at least 2 h after the elimination of the drug from the blood serum. The physiological response of reduction of body temperature may protect the mouse against the effect of the toxic chemical species involved in the induction of neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454559      PMCID: PMC2009961          DOI: 10.1038/bjc.1979.149

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain.

Authors:  L M MCEWEN
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

2.  The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.

Authors:  M E Saunders; S Dische; P Anderson; I R Flockhart
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.

Authors:  H D Kogelnik; J H Meyer; K Jentzsch; T Szepesi; K H Kärcher; E Maida; B Mamoli; P Wessely; F Zaunbauer
Journal:  Br J Cancer Suppl       Date:  1978-06

4.  Peripheral neuropathy related to misonidazole: incidence and pathology.

Authors:  R C Urtasun; J D Chapman; M L Feldstein; R P Band; H R Rabin; A F Wilson; B Marynowski; E Starreveld; T Shnitka
Journal:  Br J Cancer Suppl       Date:  1978-06

5.  Effects of sensitizers on cell respiration: 1. Factors influencing the effects of hypoxic cell radiosensitizers on oxygen utilization of tumour and cultured mammalian cells.

Authors:  J E Biaglow; C L Greenstock; R E Durand
Journal:  Br J Cancer Suppl       Date:  1978-06

6.  Effects of sensitizers on cell respiration: III. The effects of hypoxic cell radiosensitizers on oxidative metabolism and the radiation response of an in vitro tumour model.

Authors:  R E Durand; J E Biaglow; C L Greenstock
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Metronidazole (Flagyl): degradation by the intestinal flora.

Authors:  A J Searle; R L Willson
Journal:  Xenobiotica       Date:  1976-08       Impact factor: 1.908

8.  Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.

Authors:  R C Urtasun; P Band; J D Chapman; H R Rabin; A F Wilson; C G Fryer
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

9.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

10.  The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse.

Authors:  D G Hirst; B Vojnovic; I J Stratford; E L Travis
Journal:  Br J Cancer Suppl       Date:  1978-06
View more
  3 in total

1.  Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.

Authors:  M S Edwards; S K Powers; R A Baringer; D L Jewett; C Bolger; T L Phillips
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

2.  Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.

Authors:  P J Conroy; R Von Burg; D P Penney; W Passalacqua; R M Sutherland
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

3.  Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

Authors:  C Clarke; K B Dawson; P W Sheldon
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.